Latest News about GSK
Recent news which mentions GSK
Why Did HC Wainwright Beef Up Vir Biotech's Target Price?
November 30, 2021
From Benzinga
Better Pharma Stock: GlaxoSmithKline vs. Bristol-Myers Squibb
November 30, 2021
From Motley Fool
From MarketWatch
VIR Stock Pops Amid Renewed Omicron Variant Concerns. Here’s Why.
November 30, 2021
From InvestorPlace
From Benzinga
Cathie Wood Goes Bargain Shopping -- 3 Troubled Stocks She Just Bought
November 29, 2021
From Motley Fool
Who Would Be the Best FDA Commissioner for Biotech Investors?
November 28, 2021
From Motley Fool
WHO urges world leaders not to have knee-jerk reaction to new coronavirus variant from South Africa as UK and EU impose travel bans
November 26, 2021
From MarketWatch
From Benzinga
The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug
November 23, 2021
From Benzinga
GlaxoSmithKline Pens $1B Pact For NASH Candidate With Arrowhead
November 23, 2021
From Benzinga
Will Investors Benefit From Johnson & Johnson's Breakup?
November 23, 2021
From Motley Fool
2 Cheap Pharma Stocks That Pay A Tidy Dividend
November 22, 2021
From Motley Fool
CureVac's COVID-19 Vax Shows Comparable Antibody Levels To Pfizer/BioNTech's Shot In Animal Study
November 18, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
November 18, 2021
From Benzinga
Europe is the only region where COVID-19 deaths rose in the latest week, and U.S. to greatly expand vaccine manufacturing
November 17, 2021
From MarketWatch
US Government Agrees To Purchase GSK-Vir Biotech's COVID-19 Antibody Doses Worth $1B
November 17, 2021
From Benzinga
The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment
November 17, 2021
From Benzinga
This Treasury dealer says the market has it entirely wrong on the Fed and interest rates. Here’s why.
November 17, 2021
From MarketWatch
From MarketWatch
Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows
November 17, 2021
From Motley Fool
GSK, Vir's Intramuscularly-Administered Sotrovimab Shows Efficacy At Par With IV Route In COVID-19
November 12, 2021
From Benzinga
3 Vaccine Stocks With Big Opportunities Outside of COVID-19
November 11, 2021
From Motley Fool
GlaxoSmithKline Spotlights Encouraging Data For Anemia Drug
November 08, 2021
Tickers
GSK
From Benzinga
Why Vir Biotechnology Stock Is Sliding Today
November 05, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 5, 2021
November 05, 2021
From Benzinga
The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
November 05, 2021
From Benzinga
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
